发明名称 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (hepatitis C).
摘要 Disclosed herein are compounds of formula (I), wherein R1 is hydroxy or NHSO2R1A wherein R1A is (C1-8)alkyl, (C3-7)cycloalkyl or {(C1-6)alkyl-(C3-7)cycloalkyl}, which are all optionally substituted from 1 to 3 times with halo, cyano, nitro, O-(C1-6)alkyl, amido, amino or phenyl, or R1A is C6 or C10 aryl which is optionally substituted from 1 to 3 times with halo, cyano, nitro, (C1-6)alkyl, O-(C1 6)alkyl, amido, amino or phenyl; R2 is (C4-6)cycloalkyl; R3 is t-btuyl or (C5-6)cycloalkyl and R4 is (C4-6)cycloalkyl; or a pharmaceutically acceptable salt thereof. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of Hepatitis C.
申请公布号 ZA200405933(B) 申请公布日期 2005.09.05
申请号 ZA20040005933 申请日期 2004.07.26
申请人 BOEHRINGER INCGELHEIM INTERNATIONAL GMBH. 发明人 MONTSE LLINAS-BRUNET;VIDA J. GORYS
分类号 A61K45/00;A61K31/7056;A61K38/00;A61K38/21;A61K38/43;A61K38/55;A61P1/16;A61P31/14;A61P43/00;C07K5/08;C07K5/083;C07K5/087 主分类号 A61K45/00
代理机构 代理人
主权项
地址